Ultragenyx Pharma (RARE) Misses Q4 EPS by 14c, provides guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/2/2026
- Wall St rises as oil falls heading into US midterm elections, more earnings
- Marvell agrees $115 billion all-stock deal to buy Lumentum
- Oil drops 6% as Iran signals openness to peace talks
- Why has the market become so unforgiving of AI earnings?
- EchoStar rises on report SpaceX in talks to buy Boost Mobile or tap its network
| ULTRAGENYX PHARM (NASDAQ: RARE) | Delayed: 16.18 +0.08 (0.50%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $16.10 | 52 Week High | $117.12 | |||
| Open | $16.29 | 52 Week Low | $46.52 | |||
| Day High | $16.37 | P/E | N/A | |||
| Day Low | $15.85 | EPS | $-1.97 | |||
| Volume | 583,296 | |||||
